Accelerating Dermatology Prior Auth with SMART on FHIR Integration

Klivira delivers a robust dermatology SMART on FHIR prior auth solution, embedding critical automation directly into your EMR workflow. Streamline high-volume requests for biologics and specialty procedures.

Prior authorization for dermatology treatments, particularly biologics and Mohs surgery, places significant administrative burden on clinical staff. Traditional manual processes involving context-switching between the EMR and external payer portals lead to delays, errors, and clinician burnout. Klivira addresses these challenges by integrating prior authorization directly into the EMR via SMART on FHIR, transforming a fragmented workflow into a seamless, in-context experience.

The Unique Prior Authorization Landscape in Dermatology

Dermatology practices face complex prior authorization requirements for high-cost medications like biologics (e.g., Dupixent, Cosentyx, Tremfya, Skyrizi) for psoriasis and atopic dermatitis, as well as for procedures like Mohs surgery. These PAs often demand extensive documentation, including specific disease severity scores (PASI, EASI) and evidence of step therapy compliance, creating significant administrative overhead.

Common Prior Authorization Triggers in Dermatology

Biologics for psoriasis, psoriatic arthritis, and atopic dermatitis (e.g., adalimumab, secukinumab, dupilumab).
Specialty topical medications and advanced skin cancer treatments.
Mohs micrographic surgery, especially for non-melanoma skin cancers in cosmetically sensitive areas.
Home phototherapy (narrowband UVB, excimer laser) prescriptions.
Periodic re-authorization for chronic biologic therapies.

Transforming Dermatology PA with SMART on FHIR

Klivira leverages SMART on FHIR to embed prior authorization workflows directly within your EMR, including Epic, Cerner, athenahealth, and MEDITECH. This approach eliminates the need for clinicians or PA coordinators to switch applications, automatically pulling patient and encounter context via FHIR R4 to populate PA requests and reducing manual data entry errors.

Streamlined Workflow: From Order to Approval

Launch Klivira's application directly from within the EMR UI with patient context pre-populated.
Automated retrieval of clinical data (e.g., diagnosis, lab results, medication history) via US Core FHIR resources.
Guideline-aware logic for AAD Clinical Guidelines and NCCN, including step therapy validation for biologics.
Submission of prior authorization requests via Da Vinci PAS, integrated with payer portals and X12 278 channels.
Structured write-back of PA status and decisions to the EMR as DocumentReference or Task resources.

Mitigating Common Dermatology PA Denials

Klivira's platform is designed to address frequent dermatology PA denial reasons, such as insufficient documentation of step therapy trials for biologics, lack of disease severity scores (PASI, EASI), or Mohs AUC mismatches. By guiding users through documentation requirements and validating against clinical guidelines, we help ensure submissions are complete and accurate from the outset.

Klivira's Comprehensive Prior Authorization Solution

Klivira's platform provides end-to-end prior authorization automation tailored for dermatology. From initial coverage discovery via Da Vinci CRD to documentation assembly using Da Vinci DTR and final submission, our system integrates seamlessly. This ensures compliance with payer requirements for medical vs. pharmacy benefit routing and manages the complexities of periodic re-authorizations for chronic conditions.

Frequently asked questions

How does SMART on FHIR benefit dermatology practices specifically?

For dermatology, SMART on FHIR significantly reduces the administrative burden associated with high-volume prior authorizations for biologics and Mohs surgery. It eliminates context-switching, allowing clinicians and coordinators to initiate and manage PAs directly within their EMR. This reduces manual data entry, minimizes errors, and keeps the PA workflow integrated with the patient's chart, improving efficiency and reducing delays for critical treatments.

Which EMR systems does Klivira support for SMART on FHIR integration in dermatology?

Klivira's SMART on FHIR integration is designed to work with leading EMR systems commonly used in dermatology practices, including Epic, Cerner, athenahealth, and MEDITECH. Our platform leverages standard SMART App Launch protocols to ensure seamless connectivity and data exchange, providing a consistent user experience regardless of the underlying EMR vendor.

How does Klivira handle the specific documentation requirements for dermatology biologics?

Klivira incorporates guideline-aware logic that aligns with AAD Clinical Guidelines for biologics used in psoriasis and atopic dermatitis. Our system prompts for and helps validate critical documentation, such as PASI/BSA or EASI scores, evidence of prior topical or systemic therapy trials, and necessary pre-biologic screenings like TB and hepatitis. This ensures submitted requests meet payer criteria and reduces the likelihood of denials.

Can Klivira manage re-authorizations for chronic dermatology conditions?

Yes, Klivira's platform is built to manage the recurring prior authorization cycles common in chronic dermatology conditions requiring biologics. Our system tracks re-authorization timelines and proactively triggers workflows to ensure continuous coverage. This feature is crucial for maintaining treatment continuity for patients with conditions like psoriasis, atopic dermatitis, and hidradenitis suppurativa.

Does Klivira support prior authorization for Mohs micrographic surgery?

Absolutely. Klivira's system includes specific workflows for Mohs micrographic surgery, validating against Appropriate Use Criteria (AUC) and common payer policies. It helps ensure that documentation regarding tumor type, location (especially cosmetically or functionally sensitive areas), and medical necessity is complete and accurate, reducing denials related to AUC mismatches.